nctId stringlengths 11 11 | briefTitle stringlengths 7 300 | briefSummary stringlengths 2 5.11k | detailedDescription stringlengths 0 32.3k | eligibilityCriteria stringlengths 0 20.1k | embedding sequencelengths 256 256 |
|---|---|---|---|---|---|
NCT05004103 | Cosmetic Products and Facial Skin Microbiome | The skin microbiome diversity in female healthy volunteers will be studied along with cosmetic products application in 1 month period. This study is also aimed to investigate the efficacy of cosmetic products on skin rejuvenation. . | The study is conducted in COVID-19 pandemic era, thus every person involved in this study must follow health protocol for COVID-19.
The study procedure, consist of screening visit (D -7), 7-day wash out, baseline visit (D 0), first follow up ( D 14), and second follow up (D 28).
1. Screening visit: obtained Informed ... | Inclusion Criteria:
1. female 18-35 years old
2. signed the informed consent
Exclusion Criteria:
1. infected by COVID-19
2. females with skin diseases on face and neck such as atopic dermatitis, skin allergy, acne with moderate and severe degree, seborrheic dermatitis, malignancy
3. females with ongoing skin treatme... | [
0.24811390042304993,
1.4615020751953125,
-3.027015447616577,
-1.3852750062942505,
-2.889111042022705,
0.36274683475494385,
-1.6635258197784424,
-1.2331764698028564,
-0.23523978888988495,
-2.311378002166748,
1.953733205795288,
2.2179338932037354,
-1.0287556648254395,
2.512047290802002,
1.... |
NCT02491125 | The Effect of Prebiotics on Gastrointestinal Functioning and Metabolism | The study will investigate the effect of cereal based prebiotic fibres on intestinal health and functioning and host metabolism. | A human dietary intervention study will be performed in overweight to obese subjects with a slow gastrointestinal transit time comparing the effects of a soluble prebiotic fibre vs. placebo on gut health, including gut microbiota composition, gastrointestinal transit time, metabolic health and quality of life. | Inclusion Criteria:
* Overweight to obese men and women (BMI ≥ 25 kg/m2 \<35 kg/m2)
* Aged 20-50 years
* Caucasian
* Normal fasting glucose (\<6.1 mmol/L.)
* Normal blood pressure (systolic blood pressure 100-140 mmHg, diastolic blood pressure 60-90 mmHg)
* Weight stable in last 3 months (±2 kg)
* A low defecation fre... | [
2.3028714656829834,
2.1860015392303467,
-2.7412283420562744,
-4.523102760314941,
-1.07292902469635,
-1.6748192310333252,
-0.20096752047538757,
-2.1586830615997314,
-1.5441138744354248,
-0.13048505783081055,
3.1300148963928223,
3.5258002281188965,
-1.0709389448165894,
2.1400513648986816,
... |
NCT05314530 | The ReTA-model: Rehabilitation Trail for Workers on Long-term Sick Leave in the Healthcare Sector | The ReTA-model is a rehabilitation model for return to work after long-term sickness absence (LTSA) due to stress or burnout. The ReTA-model will be validated in this trial among nurses and physicians currently in LTSA. The ReTA-model includes a three-week treatment with exercise, individual and collegial talks with ps... | The ReTA-model is a rehabilitation model for return to work after long-term sickness absence (LTSA) due to stress or burnout. The ReTA-model will be validated in this trial among nurses and physicians currently in LTSA. The ReTA-model includes a three-week treatment with exercise, individual and collegial talks with ps... | Inclusion Criteria:
* currently on sick leave for burnout
* employed in the Swedish healthcare services as a nurse or as a physician
Exclusion Criteria:
- | [
-0.29594749212265015,
2.0839767456054688,
-0.35976672172546387,
-0.9271435141563416,
0.2100742906332016,
1.1273210048675537,
-0.814518928527832,
0.9756911993026733,
-1.0171178579330444,
-0.6525932550430298,
-0.6681374907493591,
1.4214431047439575,
-0.8775009512901306,
0.2315920740365982,
... |
NCT01672385 | Improving Transition Outcomes Through Accessible Health IT and Caregiver Support | Background: Older hospitalized adults frequently experience preventable short-term readmissions due to inadequate transition support. Although proactive telephone follow-up improves transition outcomes, these services often are unsystematic and of low intensity. Informal caregivers are invaluable for ensuring successfu... | Methods: 846 older adults with complex chronic conditions will be identified upon admission to two community-based acute care medical services. Patients will be asked to identify a CarePartner (CP) living outside their household, i.e., an adult child or other social network member willing to play an active role in thei... | Inclusion Criteria:
* Being discharged from study site with any diagnoses that indicate a chronic condition with a high risk of short-term readmission, for example: stroke, heart failure, coronary artery disease, cardiac arrhythmias, chronic obstructive pulmonary disease, peripheral vascular disease, deep venous throm... | [
-1.6714149713516235,
4.68118953704834,
-1.8228741884231567,
-1.8899508714675903,
-0.30254366993904114,
0.0932735726237297,
-0.5662623643875122,
0.5891757607460022,
0.6219096183776855,
-0.1337825357913971,
0.024038054049015045,
1.1168333292007446,
-1.37208890914917,
-0.44182294607162476,
... |
NCT06519331 | Development of a New Method for Liver Stiffness Measurement Using FibroScan | This is an European, prospective, interventional, multicenter clinical investigation that will take place in 2 French sites. 114 adults patients will be included. The study objective is to develop a new method for measuring liver stiffness using FibroScan. | Inclusion Criteria:
* Adult patients (≥ 18 years of age) followed in the hepatology or endocrinology department for liver disease, suspected liver disease or consequences of liver disease, all etiologies combined.
* Adult patient able to give his written consent
* Patient affiliated to the French Social Security syste... | [
1.3887207508087158,
2.9548492431640625,
-2.713205575942993,
-1.521924614906311,
-1.5879406929016113,
-0.28875279426574707,
-0.2595203220844269,
-1.1892542839050293,
-0.15110546350479126,
0.7740432024002075,
0.519034743309021,
0.22464938461780548,
-0.8407936692237854,
0.07342872023582458,
... | |
NCT03200366 | Comparing Interventions to Increase Colorectal Cancer Screening | The purpose of this study is to test different approaches to help people understand the purpose of colorectal cancer (CRC) screening, two screening test options available, and the barriers to screening so they can make informed decisions about CRC screening. Participants will be randomly assigned to one of three groups... | Colorectal cancer (CRC) often can be prevented through regular screening and although multiple screening tests are available, colonoscopy is often the only screening test offered to patients. Unfortunately, up to half of people in some hospitals who receive a recommendation and are scheduled for colonoscopy do not comp... | Inclusion Criteria:
* Referred for a screening colonoscopy that was not done (i.e, canceled or no show)
Exclusion Criteria:
* Unable to speak, read, and write English
* Personal history of CRC or polyps
* Personal history of conditions that place participants at high risk for CRC such as ulcerative colitis, Crohn's ... | [
-0.43874770402908325,
3.240760564804077,
-2.2535033226013184,
-1.5102076530456543,
0.25299662351608276,
-0.5075250267982483,
-1.0911262035369873,
-0.8666471838951111,
0.9362261295318604,
0.44514134526252747,
0.0730726569890976,
0.8789067268371582,
-0.32459577918052673,
0.617209792137146,
... |
NCT03163745 | Asymptomatic Spontaneous Bacterial Peritonitis in Patients With Decompensated Liver Cirrhosis | Spontaneous bacterial peritonitis is defined as the presence of an infection in a previously sterile ascites in the absence of an intra-abdominal source of infection or malignancy .
The variants of Spontaneous bacterial peritonitis includes - (i) Classic Spontaneous bacterial peritonitis: -ascitic fluid polymorphonucl... | Spontaneous bacterial peritonitis is a serious complication in patient with decompensated liver cirrhosis . The incidence in ascetic patients varies between 7-30 % as a consequence result of impaired defense mechanism and increased susceptibility to bacterial infection in cirrhotic patients with ascites Spontaneous bac... | Inclusion Criteria:
Patients diagnosed with decompensated liver cirrhosis with ascites (Child B and C) regardless of the etiology of liver cirrhosis
Exclusion Criteria:
1. Symptomatic spontaneous bacterial peritonitis (patients with fever, abdominal pain or tenderness, leucocytosis, hepatic encephalopathy, impaired ... | [
2.0471675395965576,
0.17826581001281738,
-3.388561248779297,
-3.0379247665405273,
0.8719542026519775,
0.3259132206439972,
-1.475311040878296,
-0.5075390338897705,
-2.1920599937438965,
1.4968703985214233,
0.1828952431678772,
0.9357412457466125,
1.2501870393753052,
1.967971682548523,
0.731... |
NCT01748019 | ST1968 Intravenous (Weekly) in Solid Tumors | ST1968 is a novel camptothecin derivative which interacts with topoisomerase I-DNA complex, inducing S-Phase specific cytotoxicity. It is endowed with a potent antitumor activity and an increased Therapeutic Index with respect to the clinically used analogues (i.e.irinotecan and topotecan) in some xenograft models (ova... | Multicenter, open label, uncontrolled Phase I pharmacokinetic trial to determine the Maximum Tolerated Dose (MTD) of ST1968 given intravenously (I.V.) once every week for 2 consecutive weeks every 3 weeks and the MTD of ST1968 given I.V. once every 3 weeks. A starting dose of 1.5mg/m2 given as a flat dose of 2.5mg is d... | Inclusion Criteria:
* Histological/cytological diagnosis of solid tumors for which therapy of proven efficacy does not exist.
* Preferably measurable disease
* ECOG performance status ≤ 1.
* Age ≥ 18 years.
* Ongoing toxicity associated with prior anticancer therapy ≤ grade 1 (NCI-CTCAE V3.0).
* Maximum of 2 prior che... | [
1.203084945678711,
-0.5571659803390503,
-2.753296136856079,
-2.3126816749572754,
0.20999112725257874,
-0.7948271632194519,
-0.5745067596435547,
0.6638303995132446,
-0.8284300565719604,
0.21575598418712616,
0.644280731678009,
-0.15062685310840607,
0.19081586599349976,
0.15381476283073425,
... |
NCT00179985 | The Impact of Implementing NIDCAP on the Developmental Sensitivity of Nurses Caring for Preterm Infants | The purpose of this study is to determine whether implementing the Newborn Individualized Developmental Care and Assessment Program increases NICU nurses' sensitivity in meeting the developmental care needs of preterm infants. | Therapies that have brought about sharp decreases in neonatal mortality have not brought about similar decreases in neurodevelopmental morbidity for preterm infants. Developmentally supportive care is NICU (Neonatal Intensive Care Unit) care that seeks to optimize the developmental course and outcomes for preterm infan... | Inclusion Criteria:
* be an RN,
* be an employee of the NICU at the study site,
* have completed the NICU nursing orientation at the study site,
* work at least 0.4 FTE in the NICU at the study site, and
* be observed while caring for a preterm infant born at less than or equal to 36 weeks gestation and at less than o... | [
0.44354763627052307,
4.76747989654541,
-4.879358291625977,
-2.9753267765045166,
0.014662102796137333,
-0.09011711925268173,
-0.9947158098220825,
1.0534032583236694,
0.38669347763061523,
0.08772334456443787,
0.07468016445636749,
3.3197073936462402,
-2.0592408180236816,
1.1049003601074219,
... |
NCT06651905 | Nerve Block Vs Sedation Infusion for Awake Fiberoptic Intubation. | This study compares the efficacy and safety of dexmedetomidine infusion versus superior laryngeal nerve block during awake fiberoptic intubation in hemimandibulectomy patients. | Inclusion Criteria:
* Age range ≥ 18 or ≤60.
* Both sexes.
* American Society of Anesthesiologists (ASA) II-III.
* Body mass index:18.5 to 30 kg/m2.
* Hemimandibulectomy patients with an anticipated difficult airway \[El-Ganzouri Risk Index (EGRI)\>3\].
Exclusion Criteria:
* Patient's refusal.
* Known allergy to dru... | [
0.12851931154727936,
-1.4189200401306152,
-4.379291534423828,
-5.220954895019531,
0.7194960117340088,
-1.036827802658081,
1.3738596439361572,
3.4728426933288574,
-1.2545286417007446,
0.8496637344360352,
0.02809700183570385,
2.5824942588806152,
-0.19697508215904236,
1.5740519762039185,
2.... | |
NCT02689102 | Confocal Laser Endomicroscopy and Optical Coherence Tomography for Diagnosing ILD. | Often, assessing a classifying diagnosis in patients with interstitial lung disease provides a diagnostic challenge. Currently HRCT, endoscopic or surgical video assisted thoracoscopic surgery(VATS) assessment including lung biopsies are diagnostic tools for patients with suspected ILD. However, tissue acquisition is a... | Novel probe based optical techniques such as Confocal laser endomicroscopy (pCLE) and Optical coherence tomography (pOCT) are non-invasive optical techniques, compatible with conventional diagnostic bronchoscopes and provide non-invasive, real-time information on the airway wall and the alveolar compartment. Therefore,... | Inclusion Criteria:
* 18 years of age
* Supected ILD and referred for diagnostic bronchoscopic procedure with cryobiopsy
Exclusion Criteria:
* Smoked in the last 6 months
* Inability and willingness to provide informed consent
* Inability to comply with the study protocol | [
0.7067266702651978,
4.010557174682617,
-2.962890625,
-2.688214063644409,
-1.25055730342865,
-1.4053646326065063,
-1.4000145196914673,
-0.7344356775283813,
-1.9925756454467773,
0.7961294054985046,
1.6718437671661377,
1.9034044742584229,
-0.737353503704071,
0.4133990406990051,
-0.416962057... |
NCT00000614 | Prevention of Recurrent Venous Thromboembolism (PREVENT) | A multicenter randomized, double blind placebo controlled trial to determine the efficacy of long-term, low dose warfarin in the secondary prevention of venous thromboembolism. | BACKGROUND:
Venous thromboembolism is associated with more than 300,000 hospitalizations and results in thousands of deaths annually. Conventional therapy consists of intravenous heparin followed by oral anticoagulants usually given for three to six months. The recommended intensity of oral anticoagulants (warfarin) h... | Patients with venous thromboembolism, including patients with factor V Leiden. Patients had completed prescribed anticoagulation therapy within the last two years before the trial and were not currently on anticoagulation therapy. | [
-0.5140213966369629,
2.5616562366485596,
-2.1750237941741943,
-2.9154176712036133,
0.8068423271179199,
-0.017048321664333344,
-0.7714412212371826,
0.7772365808486938,
-0.2669714689254761,
-0.2443625032901764,
0.40067869424819946,
1.043558955192566,
-1.4293873310089111,
0.1441734880208969,
... |
NCT01997450 | A Case Control Study of the Effectiveness of Q/LAIV Versus Inactivated Influenza Vaccine and No Vaccine in Subjects 2-17 Years of Age | This is a post-marketing case-controlled study of the effectiveness of a quadrivalent live attenuated influenza vaccine (Q/LAIV/FluMist® Quadrivalent) versus Inactivated Influenza Vaccine (IIV) and No Vaccine in subjects 2-17 years of age. | This post-marketing study will enroll approximately 5,200 subjects 2-17 years of age who are seeking care in an outpatient setting for febrile acute respiratory illness. This study will begin in the fall of 2013 and will be completed after 4 influenza seasons (i.e.after the 2016-2017 influenza season). No investigation... | Inclusion Criteria:
* Community-dwelling children and adolescents 2 to 17 years of age.
* Written Informed Consent or Assent.
* Acute respiratory illness documented at study visit or at home with fever (oral temperature ≥ 100.0° Fahrenheit at study visit, or history of fever reported by parents, or use of antipyretic ... | [
0.2172827571630478,
1.85748291015625,
-2.414210796356201,
-2.748455762863159,
0.03439657762646675,
1.9876079559326172,
0.588137149810791,
2.1689634323120117,
0.09315908700227737,
-1.6131093502044678,
0.028601065278053284,
2.7039263248443604,
-1.8535300493240356,
0.7625525593757629,
-0.96... |
NCT01590017 | Cisplatin and Radiation Therapy in Treating Patients With HIV-Associated Locally Advanced Cervical Cancer | RATIONALE: Drugs used in chemotherapy, such as cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Radiation therapy uses high-energy x rays to kill tumor cells. Giving cisplatin together with radiation therapy may be an effective treatment... | OBJECTIVES:
Primary
* To determine if it is feasible to administer a regimen of cisplatin/radiotherapy in HIV-infected women with locally advanced cervical cancer (LACC) on antiretroviral therapy (ART).
* To evaluate the safety and tolerability of concomitant chemoradiotherapy with cisplatin in HIV-infected women wit... | DISEASE CHARACTERISTICS:
* Participants (who have been adequately clinically staged by standard clinical guidelines) with primary, untreated, histologically confirmed, documented invasive squamous cell carcinoma, adenocarcinoma, or adenosquamous carcinoma of the uterine cervix, stages IB2, IIA, IIB, IIIA, IIIB, and IV... | [
1.3239103555679321,
2.8077750205993652,
-0.9694240093231201,
-3.1274731159210205,
-1.3011395931243896,
-1.5849249362945557,
-1.903984546661377,
-0.8742843270301819,
-3.1325199604034424,
-0.4716801047325134,
-1.259921908378601,
2.066389322280884,
-0.6148751378059387,
-0.6610634922981262,
... |
NCT03184896 | Services Mapping Among Older Adults With Hip Fracture | Hip fracture is a osteoporosis-related fracture with higher mortality, and is a major public health issue in China. The British Orthopedic Association and the British Geriatric Society have published the UK Blue Book, which summarizes current evidence and best practice in the hip fracture care and secondary prevention,... | Inclusion Criteria:
* Adults aged 65 years old or over;
* Hip fracture with X-ray-confirmed femoral neck, trochanteric or sub-trochanteric fracture;
* Within 21 days of a hip fracture;
* Willingness to sign informed consent form;
Exclusion Criteria:
* Patients with pathological fractures;
* With terminal malignancie... | [
0.6678895950317383,
3.1394717693328857,
-2.7444658279418945,
-0.614854633808136,
1.265476107597351,
0.08387909829616547,
-0.27254197001457214,
-1.2451509237289429,
-0.3346720337867737,
-0.04465009272098541,
0.3033130168914795,
1.4698846340179443,
0.17979228496551514,
-1.4140338897705078,
... | |
NCT03969524 | Functional MRI in Predicting Response to Chemotherapy | • Address the accuracy of functional MRI techniques to predict response to neoadjuvant chemotherapy given to local advanced breast cancer patients with correlation with pathology thus allowing early chemotherapy regimen modification to increase number of patients achieving pathological complete response or save patient... | patient selection:
Selection of patients diagnosed with of biopsy proven breast cancer (BIRAD VI ) :
• Inclusion criteria: patient in different age groups with local advanced breast cancer who are eligible for neoadjuvant chemotherapy and breast conservative surgery and in need for clip placement for tumor localizati... | Inclusion Criteria:
* patient in different age groups with local advanced breast cancer who are eligible for neoadjuvant chemotherapy and breast conservative surgery and in need for clip placement for tumor localization
Exclusion Criteria:
* Patient with breast cancer who are not eligible for NAC (pregnant patients,... | [
0.6617687344551086,
4.860845565795898,
-1.7360633611679077,
-2.889803409576416,
-0.30887967348098755,
-1.4824433326721191,
-2.1030304431915283,
-1.497694730758667,
-2.64605712890625,
-0.829935610294342,
-1.1171938180923462,
2.5709123611450195,
0.03954678028821945,
1.5437731742858887,
-0.... |
NCT04334616 | POST: Comparison of Macintosh Laryngoscope vs Video Laryngoscope in Patients Intubated by Anaesthesia Trainee | OBJECTIVES The objective of this study is to compare the frequency of POST in patients intubated by trainee anaesthetist using Video LaryngoscopeTM(VDL) versus Conventional Macintosh Laryngoscope (CL) at a tertiary care hospital in Karachi, Pakistan
OPERATIONAL DEFINITIONS
1. Sore Throat: A sore throat is pain, scrat... | MATERIAL AND METHODS
SETTING: The study will be conducted at main Operating Room, Department of Anaesthesiology, Aga Khan University Hospital Karachi.
DURATION OF STUDY: This study will be conducted for a period of one year or till the completion of sample size after approval of synopsis by ERC and CPSP.
SAMPLE SIZE... | Inclusion Criteria:
1. All adult patient of age between 20-60 year
2. American society of Anesthesiologist grade I and II
3. Scheduled for elective laparoscopic cholecystectomy
4. Both male and female genders
Exclusion Criteria:
1. Anticipated difficult airway as assessed by limited mouth opening (\< 2 finger breadt... | [
-0.0018074989784508944,
0.9772703647613525,
-2.604769229888916,
-3.123443126678467,
-0.5534586906433105,
0.15761588513851166,
0.08296643197536469,
0.7691975831985474,
-1.6616430282592773,
0.32565706968307495,
0.04199448600411415,
2.1339375972747803,
-1.520174503326416,
0.11499513685703278,... |
NCT03496948 | Telephone Health Coaching and Remote Exercise Monitoring for Peripheral Artery Disease | Peripheral artery disease (PAD) is the third most prevalent cardiovascular disease worldwide, with over 200 million people affected. Most prominent symptom is leg pain while walking known as intermittent claudication. Based on the currently existing gaps in the management of intermittent claudication, the objective of ... | Peripheral artery disease (PAD) is the third most prevalent cardiovascular disease worldwide and has become a serious public health issue, with over 200 million people affected. Smoking and diabetes are the strongest risk factors for the development of peripheral artery disease, but also high cholesterol, high blood pr... | Inclusion Criteria:
* Insured with one of the three participating health insurance companies
* Sufficient German language skills to follow the telephone-based health coaching
* Access to a telephone (landline or mobile);
* Primary or secondary diagnosis of PAD at Fontaine stage IIa or IIb within the last 36 months, bu... | [
-0.22248728573322296,
2.7504618167877197,
-1.8484516143798828,
-2.6867763996124268,
-0.32834118604660034,
0.37953445315361023,
0.5482466816902161,
0.39838990569114685,
0.4656645655632019,
0.6300077438354492,
1.5522350072860718,
1.2552419900894165,
-0.7211530208587646,
-1.020738959312439,
... |
NCT00761787 | Cardiac Allograft Rejection Gene Expression Observational (CARGO) II STUDY | The Cardiac Allograft Rejection Gene Expression Observational (CARGO) II Study is designed to provide independent evidence of the clinical performance of the non-invasive AlloMap test. Sensitive detection of cardiac allograft rejection and dysfunction is the basis for successful recipient management. The CARGO II Study... | Inclusion Criteria:
* New and existing allograft recipients
* All patients (age ≥ 18years) receiving post-transplant care at the enrolling centers
Exclusion Criteria:
* Concurrent enrollment in a double-blind drug trial (immunosuppressive drugs). | [
0.05473295599222183,
3.562605381011963,
-1.4828230142593384,
-1.7102187871932983,
0.6776442527770996,
-0.13652728497982025,
-0.6893916130065918,
-0.05335459113121033,
-1.3458276987075806,
-0.03756733983755112,
0.3138573467731476,
1.1899014711380005,
-1.2605867385864258,
0.8673900961875916,... | |
NCT02873585 | Conventional Bite Wing Radiography Versus Stationary Intraoral Tomosynthesis, a Comparison Study | A comparison of caries detection rates between conventional intraoral bitewing radiography and a stationary intraoral digital tomosynthesis (s-IOT) using a carbon nanotube X-ray source array. The secondary objective is to assess participants experience with the s-IOT device. | The primary purpose of this study is to compare caries detection rates between conventional intraoral bitewing radiography and a stationary intraoral digital tomosynthesis (s-IOT) using a carbon nanotube X-ray source array. Patient experience with the s-IOT device will be assess using a short questionnaire.
Fifty adul... | Inclusion Criteria:
* 18 years and older
* Scheduled for horizontal BW or Full (FMX) with horizontal BWs
* Patients who have in the right and left maxilla and mandible at least a canine and two posterior teeth that are in contact
* At least one proximal caries lesion in a surface of a posterior tooth (premolar or mola... | [
1.5161105394363403,
1.2917308807373047,
-3.189117193222046,
-5.093128204345703,
-0.4241738021373749,
0.4917645752429962,
-0.16797055304050446,
-0.9663925766944885,
-2.936183452606201,
2.739609718322754,
0.4070281386375427,
-0.6259357929229736,
-2.0261521339416504,
0.9953590035438538,
1.0... |
NCT02547740 | Macular Damage in Early Glaucoma and Progression | Glaucoma is the leading cause of irreversible blindness worldwide. This study aims to test a new method that may allow earlier diagnosis of glaucoma and better ways to monitor if it is getting worse. There is scientific evidence that the macula, the central part of the retina, can be involved in very early stages of gl... | There is compelling evidence that glaucomatous damage to the macula occurs even in early stages of the disease. The macula comprises about 30% of all retinal ganglion cells and its information corresponds to over 50% of the visual cortex. However, glaucomatous damage to the macula is often missed in clinical practice. ... | Glaucoma Group:
Inclusion Criteria:
* glaucomatous optic neuropathy (as defined in the American Academy of Ophthalmology Preferred Practice Pattern criteria)
Exclusion Criteria:
* late functional glaucomatous damage
* significant cataract
* previous ocular surgery (aside from uncomplicated cataract extraction with ... | [
0.12394456565380096,
1.7415838241577148,
-1.2463765144348145,
-2.7576136589050293,
-0.6571207642555237,
0.26382213830947876,
-0.4793376624584198,
-1.1932792663574219,
-1.1831783056259155,
0.450825959444046,
0.8011161088943481,
0.7078351378440857,
-1.5742356777191162,
0.07531320303678513,
... |
NCT00910715 | Duration of Antibiotic Treatment of Erythema Migrans | The purpose of this study is to compare the efficacy of 15-day versus 10-day doxycycline treatment in patients with erythema migrans. | Inclusion Criteria:
* solitary erythema migrans in patients \> 15 years
Exclusion Criteria:
* a history of Lyme borreliosis in the past
* pregnancy or lactation
* immunocompromised status
* serious adverse event to doxycycline
* taking antibiotic with antiborrelial activity within 10 days
* multiple erythema migrans... | [
0.7956280708312988,
0.7373046278953552,
-1.3782716989517212,
-1.0280580520629883,
0.28712400794029236,
-0.13810163736343384,
0.8416576981544495,
0.596087634563446,
0.17747217416763306,
0.15861691534519196,
-0.2438708245754242,
2.2069547176361084,
-1.206742763519287,
0.6954351663589478,
1... | |
NCT06307210 | Is Inpatient Rehabilitation Effective for Very Old Patients? | The goal of this retrospective longitudinal observational study is to compare the effects of physical and mental performance as well as quality of life in patients with neurological and musculoskeletal disorders.
The main question it aims to answer is: Do very old patients benefit in a similar way from inpatient rehab... | Inpatient rehabilitation has been shown to improve exercise capacity and quality of life in patients with neurological and musculoskeletal disorders.
Rehabilitation in Valens includes intensive strength and endurance training. Expectedly improvements in physical and mental performance measured by Functional Independen... | Inclusion Criteria:
* german speaking
* age \>74
* patients with neurological and musculoskeletal disorders
Exclusion Criteria:
* age \<75
* patients with pulmonological and internal disorders | [
0.2531878352165222,
2.6992568969726562,
-1.546919345855713,
-1.6798322200775146,
0.5084161162376404,
0.9926806092262268,
0.6469154953956604,
-1.1549232006072998,
-0.23886843025684357,
0.7478058934211731,
0.28663891553878784,
1.2870579957962036,
-1.0435752868652344,
0.5503131151199341,
-0... |
End of preview. Expand in Data Studio
Clinical Trials Embeddings Dataset
Overview
This dataset contains information extracted from clinical trial records collected from ClinicalTrials.gov (Date Accessed: 05/02/2025) along with briefSummary columns embeddings generated using minishlab/potion-base-8M. It focuses on key descriptive fields that provide insight into trial objectives, eligibility criteria, and study design. The dataset is designed for researchers, healthcare professionals, and AI/ML practitioners interested in analyzing clinical trial data, understanding treatment development, or building tools to assist in clinical trial matching.
Dataset Structure
Each record in the dataset represents a single clinical trial and contains the following key fields:
- nctId: The unique identifier for the clinical trial as registered on ClinicalTrials.gov
- briefTitle: A short title of the study
- briefSummary: A concise summary of the trial's purpose and objectives
- detailedDescription: An extended description of the trial, including methodology and other details
- eligibilityCriteria: Specifications for who can and cannot participate in the trial
- embedding: Embeddings for the
briefSummarycolumn
- Downloads last month
- 45